BROS vs BVS · P/E 105, rev $1.28B vs rev $573.3M
Dutch Bros Inc (BROS) versus Bioventus Inc (BVS) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Bioventus Inc (BVS) is a medical devices company listed on US.
Latest reported BROS revenue for 2024-12-31 was $1.28B. Net income was $66.5M. Revenue was up 32.6% from 2023-12-31 to 2024-12-31. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. BVS currently screens at market cap $495.1M.
Not investment advice. Open the BROS and BVS stock pages for the full models.
Not investment advice.